McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxOcGR6UUp2Q1I3OGZzMms2SjRGM3A5ZV84Z1J5SzhLOUF4eG9zblRWMjRGRHc3NWdOa28xOXlCS3FxTWRydHJxTjFqZUMxWVRkbnNENlpWbF82aVBBSlFydmgyVEFaQV94WlpXZlpuOW1JTWJZMTFldnR6bThpa2ZyMzBIaEVyeVVpdS1CYmlWZVRySC12UndlVHk3M05yM0tKY1otZHZ6VUdiWUl4WEcwY3RYdTZNeUxXdWVYNVUtNnVTSzM2M2hDYWZpZkhJdw?oc=5" target="_blank">McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMZelenskiy says letting Russia sell diesel to US is 'investment in war' - Reuters
Zelenskiy says letting Russia sell diesel to US is 'investment in war' Reuters
October 9, 2026 at 08:42 PMFour signs it is about to get uglier in the bond market as yields rise - Reuters
Four signs it is about to get uglier in the bond market as yields rise Reuters
October 9, 2026 at 04:18 PMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PM